This inventor holds 4 USPTO granted patents. Top assignees: Massachusetts Institute of Technology, University of Montreal, Ribozyme Pharmaceuticals, Incorporated. Active years: 1997-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 8,586 
2 out of 7 
1 out of 110 Years Active: 1997-2006
Title: The Innovations of Jean-Pierre Perreault
Introduction
Jean-Pierre Perreault is a notable inventor based in Rawdon, Canada. He has made significant contributions to the field of nucleic acids, particularly through his innovative work on nucleozymes. With a total of 4 patents, Perreault's inventions have the potential to impact therapeutic applications significantly.
Latest Patents
One of his latest patents focuses on nucleozymes containing ribonucleotides and deoxyribonucleotides or nucleic acid analogues. These nucleozymes exhibit catalytic activity and demonstrate a remarkable resistance to degradation compared to their all-RNA ribozyme counterparts. The patent also outlines methods for preparing these nucleozymes and their potential uses as therapeutic agents.
Career Highlights
Throughout his career, Perreault has worked with prestigious institutions, including the University of Montreal and the Massachusetts Institute of Technology. His research has contributed to advancements in the understanding and application of nucleic acids in various fields.
Collaborations
Some of his notable coworkers include Nassim Usman and Robert J. Cedergren. Their collaborative efforts have further enriched the research landscape in which Perreault operates.
Conclusion
Jean-Pierre Perreault's innovative work in the field of nucleic acids and his contributions through his patents highlight his importance as an inventor. His research continues to pave the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile